BDBM397107 2-{5-methyl-2-[5-{[3-(1H- pyrazol-1-yl)pyrazin-2-yl] carbonyl}hexahydropyrrolo[3,4-c] pyrrol-2(1H)-yl]-1,3-oxazol-4-yl} propan-2-ol::US9987255, 21

SMILES Cc1oc(nc1C(C)(C)O)N1CC2CN(CC2C1)C(=O)c1nccnc1-n1cccn1

InChI Key InChIKey=AABVUXFFHVGZGI-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 397107   

TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM397107(2-{5-methyl-2-[5-{[3-(1H- pyrazol-1-yl)pyrazin-2-y...)
Affinity DataIC50:  1.00E+4nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM397107(2-{5-methyl-2-[5-{[3-(1H- pyrazol-1-yl)pyrazin-2-y...)
Affinity DataIC50:  112nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent